EMA Seeks Public Consult on Bioequivalence Concept Paper - - BioPharm International

ADVERTISEMENT

EMA Seeks Public Consult on Bioequivalence Concept Paper


RELATED ARTICLES

More in GMPs/Validation

The European Medicines Agency has released its draft concept paper on the development of development of product-specific guidance on demonstration of bioequivalence. Public comments are open until September 30.

EMA plans to develop product-specific guidance to enable a consistent approach to the assessment of applications based on bioequivalence data across various submission routes to help companies design study programs that meet European Union regulations. The guidance will be based on EMA’s guideline on the investigation of bioequivalence.

Source: European Medicines Agency
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/07/news_detail_001866.jsp&mid=WC0b01ac058004d5c1

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

AbbVie/Shire Deal Officially Off
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Author Guidelines

Click here